PD-1 and PD-L1 Inhibitors Market to Witness Significant Growth due to Increasing Incidences of Cancer and Advancements in Immunotherapy
PD-1 and PD-L1 inhibitors are a class of immunotherapy drugs that work by blocking the interactions between PD-1 and PD-L1 proteins on cancer cells and T cells. This helps the…